Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs Southern Copper Corp (SCCO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs Southern Copper Corp — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $977.37M), while Southern Copper Corp trades at $197 (market cap $169.44B). The key difference: Southern Copper Corp is far larger — about 173.4× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and Southern Copper Corp pays a 2.19% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and Southern Copper Corp for 62 Days on average.
| MRVI | SCCO | |
|---|---|---|
Market Cap | $977.37M | $169.44B |
Volume | 2,742,564 | 888,492 |
Sector | Health | Basic Materials |
52-Week High | $9.00 | $219.70 |
52-Week Low | $2.83 | $120.02 |
Typical Hold Time | 0 Days | 62 Days |
Enterprise Value | $1.08B | $170.74B |
Dividend Yield | — | 2.19% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
Southern Copper (SCCO) trades at $207.42, down 0.61% on the day, with strong fundamental performance including 35.9% net margins and 50.1% ROE. The stock shows bullish technical signals with support at $207 and resistance at $210, while consistently beating earnings estimates in recent quarters. Revenue growth accelerated to $13.4B in 2025 with net income reaching $4.3B, supported by operational cash flow of $4.8B.
Despite premium valuations (P/E 31.1, P/S 11.2), SCCO's world-class assets and $10.2B Mexican project pipeline support long-term growth. However, analyst consensus remains cautious with only 10% buy ratings and a $165.60 price target, 20% below current levels. Key risks include copper price volatility and the stock's valuation premium relative to peers.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About Southern Copper Corp
Southern Copper Corp is an integrated producer of copper and other minerals and operates the mining, smelting, and refining facilities in Peru and Mexico. Its production includes copper, molybdenum, zinc, and silver. The company operates through the following segments: Peruvian operations, Mexican open-pit operations, and Mexican underground mining operations. Southern Copper generates the majority of its revenue from the sale of copper and the rest from the sale of non-copper products, such as molybdenum, silver, zinc, lead, and gold. Its geographical segments are The Americas, Europe, and Asia.
Read more on SCCO →
